Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
'I was diagnosed with incurable brain cancer on holiday' - 2The most effective method to Examine a Cellular breakdown in the lungs Finding with Family
- 3The Main 20 Gaming Control center Ever
- 4Yemen's Houthis ready to join Iran war if needed, raising new shipping risk
- 5I thought I knew the night sky, but what I saw from the Canary Islands left me speechless
- Individual Preparation Administrations to Raise Your Wellness Process
- In the stomach of a mummified wolf pup, scientists find DNA from a woolly rhinoceros
- Viruses aren’t all bad: In the ocean, some help fuel the food web – a new study shows how
- Zelensky warns of imminent massive Russian attack on Ukraine
- The Development of Shipping: Controlling Towards a More Associated Future
- Manual for Picking Coastline Travel
- Vote in favor of Your Number one BWM Vehicles
- Judge sets $60K bond for Florida congresswoman accused of stealing $5M in COVID-19 funds
- The Manual for Electric Vehicles that will be hot dealers in 2023
